nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Dextromethorphan—CHRNB4—lung cancer	0.00868	0.227	CrCbGaD
Levorphanol—Dextromethorphan—CHRNA3—lung cancer	0.00602	0.158	CrCbGaD
Levorphanol—Morphine—UGT1A1—lung cancer	0.00482	0.126	CrCbGaD
Levorphanol—Renal failure—Gemcitabine—lung cancer	0.00299	0.00336	CcSEcCtD
Levorphanol—Vomiting—Pemetrexed—lung cancer	0.00299	0.00336	CcSEcCtD
Levorphanol—Vomiting—Gefitinib—lung cancer	0.00297	0.00334	CcSEcCtD
Levorphanol—Rash—Pemetrexed—lung cancer	0.00297	0.00333	CcSEcCtD
Levorphanol—Dermatitis—Pemetrexed—lung cancer	0.00297	0.00333	CcSEcCtD
Levorphanol—Rash—Gefitinib—lung cancer	0.00295	0.00331	CcSEcCtD
Levorphanol—Dermatitis—Gefitinib—lung cancer	0.00295	0.00331	CcSEcCtD
Levorphanol—Estradiol—UGT1A1—lung cancer	0.00294	0.0771	CrCbGaD
Levorphanol—Sweating—Gemcitabine—lung cancer	0.00292	0.00328	CcSEcCtD
Levorphanol—Lethargy—Docetaxel—lung cancer	0.00286	0.00321	CcSEcCtD
Levorphanol—Bradycardia—Irinotecan—lung cancer	0.00286	0.00321	CcSEcCtD
Levorphanol—Respiratory failure—Methotrexate—lung cancer	0.00284	0.00318	CcSEcCtD
Levorphanol—Nausea—Pemetrexed—lung cancer	0.0028	0.00314	CcSEcCtD
Levorphanol—Renal failure—Cisplatin—lung cancer	0.00279	0.00313	CcSEcCtD
Levorphanol—Nausea—Gefitinib—lung cancer	0.00278	0.00312	CcSEcCtD
Levorphanol—Shock—Erlotinib—lung cancer	0.00275	0.00309	CcSEcCtD
Levorphanol—Hyperhidrosis—Topotecan—lung cancer	0.00273	0.00307	CcSEcCtD
Levorphanol—Visual impairment—Irinotecan—lung cancer	0.00271	0.00304	CcSEcCtD
Levorphanol—Pruritus—Teniposide—lung cancer	0.0027	0.00303	CcSEcCtD
Levorphanol—Dysuria—Paclitaxel—lung cancer	0.00267	0.003	CcSEcCtD
Levorphanol—Thinking abnormal—Doxorubicin—lung cancer	0.00263	0.00296	CcSEcCtD
Levorphanol—Palpitations—Vinorelbine—lung cancer	0.00262	0.00294	CcSEcCtD
Levorphanol—Flushing—Irinotecan—lung cancer	0.00261	0.00292	CcSEcCtD
Levorphanol—Bradycardia—Cisplatin—lung cancer	0.00259	0.00291	CcSEcCtD
Levorphanol—Dyskinesia—Doxorubicin—lung cancer	0.00257	0.00288	CcSEcCtD
Levorphanol—Renal failure—Etoposide—lung cancer	0.00256	0.00287	CcSEcCtD
Levorphanol—Coma—Methotrexate—lung cancer	0.00254	0.00286	CcSEcCtD
Levorphanol—Insomnia—Erlotinib—lung cancer	0.00253	0.00284	CcSEcCtD
Levorphanol—Arrhythmia—Irinotecan—lung cancer	0.00251	0.00282	CcSEcCtD
Levorphanol—Renal failure—Paclitaxel—lung cancer	0.00251	0.00281	CcSEcCtD
Levorphanol—Constipation—Vinblastine—lung cancer	0.00249	0.00279	CcSEcCtD
Levorphanol—Dyspepsia—Topotecan—lung cancer	0.00249	0.00279	CcSEcCtD
Levorphanol—Dyspepsia—Erlotinib—lung cancer	0.00246	0.00276	CcSEcCtD
Levorphanol—Visual impairment—Cisplatin—lung cancer	0.00246	0.00276	CcSEcCtD
Levorphanol—Arrhythmia—Gemcitabine—lung cancer	0.00244	0.00274	CcSEcCtD
Levorphanol—Vomiting—Teniposide—lung cancer	0.00242	0.00272	CcSEcCtD
Levorphanol—Constipation—Topotecan—lung cancer	0.00242	0.00271	CcSEcCtD
Levorphanol—Rash—Teniposide—lung cancer	0.0024	0.0027	CcSEcCtD
Levorphanol—Dermatitis—Teniposide—lung cancer	0.0024	0.0027	CcSEcCtD
Levorphanol—Feeling abnormal—Vinblastine—lung cancer	0.0024	0.00269	CcSEcCtD
Levorphanol—Injection site reaction—Doxorubicin—lung cancer	0.0024	0.00269	CcSEcCtD
Levorphanol—Constipation—Erlotinib—lung cancer	0.00239	0.00269	CcSEcCtD
Levorphanol—Abnormal dreams—Doxorubicin—lung cancer	0.00238	0.00268	CcSEcCtD
Levorphanol—Gastrointestinal pain—Vinblastine—lung cancer	0.00238	0.00267	CcSEcCtD
Levorphanol—Flushing—Cisplatin—lung cancer	0.00237	0.00266	CcSEcCtD
Levorphanol—Tachycardia—Vinorelbine—lung cancer	0.00236	0.00265	CcSEcCtD
Levorphanol—Muscle spasms—Irinotecan—lung cancer	0.00235	0.00264	CcSEcCtD
Levorphanol—Bradycardia—Paclitaxel—lung cancer	0.00233	0.00262	CcSEcCtD
Levorphanol—Feeling abnormal—Topotecan—lung cancer	0.00233	0.00262	CcSEcCtD
Levorphanol—Gastrointestinal pain—Topotecan—lung cancer	0.00231	0.0026	CcSEcCtD
Levorphanol—Abdominal pain—Vinblastine—lung cancer	0.0023	0.00258	CcSEcCtD
Levorphanol—Gastrointestinal pain—Erlotinib—lung cancer	0.00229	0.00257	CcSEcCtD
Levorphanol—Arrhythmia—Cisplatin—lung cancer	0.00228	0.00256	CcSEcCtD
Levorphanol—Nausea—Teniposide—lung cancer	0.00227	0.00254	CcSEcCtD
Levorphanol—Hypotension—Vinorelbine—lung cancer	0.00226	0.00254	CcSEcCtD
Levorphanol—Urticaria—Topotecan—lung cancer	0.00225	0.00252	CcSEcCtD
Levorphanol—Abdominal pain—Topotecan—lung cancer	0.00223	0.00251	CcSEcCtD
Levorphanol—Abdominal pain—Erlotinib—lung cancer	0.00221	0.00248	CcSEcCtD
Levorphanol—Visual impairment—Paclitaxel—lung cancer	0.00221	0.00248	CcSEcCtD
Levorphanol—Coma—Doxorubicin—lung cancer	0.0022	0.00247	CcSEcCtD
Levorphanol—Estrone—ABCG2—lung cancer	0.00218	0.0572	CrCbGaD
Levorphanol—Flushing—Etoposide—lung cancer	0.00217	0.00243	CcSEcCtD
Levorphanol—Muscle spasms—Cisplatin—lung cancer	0.00213	0.00239	CcSEcCtD
Levorphanol—Renal failure—Docetaxel—lung cancer	0.00212	0.00239	CcSEcCtD
Levorphanol—Flushing—Paclitaxel—lung cancer	0.00212	0.00239	CcSEcCtD
Levorphanol—Abnormal vision—Doxorubicin—lung cancer	0.0021	0.00236	CcSEcCtD
Levorphanol—Mental disability—Doxorubicin—lung cancer	0.00209	0.00235	CcSEcCtD
Levorphanol—Constipation—Vinorelbine—lung cancer	0.00207	0.00232	CcSEcCtD
Levorphanol—Lethargy—Methotrexate—lung cancer	0.00206	0.00232	CcSEcCtD
Levorphanol—Arrhythmia—Paclitaxel—lung cancer	0.00205	0.0023	CcSEcCtD
Levorphanol—Confusional state—Irinotecan—lung cancer	0.00201	0.00226	CcSEcCtD
Levorphanol—Pruritus—Topotecan—lung cancer	0.002	0.00225	CcSEcCtD
Levorphanol—Feeling abnormal—Vinorelbine—lung cancer	0.00199	0.00224	CcSEcCtD
Levorphanol—Pruritus—Erlotinib—lung cancer	0.00198	0.00222	CcSEcCtD
Levorphanol—Gastrointestinal pain—Vinorelbine—lung cancer	0.00198	0.00222	CcSEcCtD
Levorphanol—Shock—Irinotecan—lung cancer	0.00196	0.0022	CcSEcCtD
Levorphanol—Tension—Paclitaxel—lung cancer	0.00196	0.0022	CcSEcCtD
Levorphanol—Muscle spasms—Etoposide—lung cancer	0.00195	0.00219	CcSEcCtD
Levorphanol—Nervousness—Paclitaxel—lung cancer	0.00194	0.00217	CcSEcCtD
Levorphanol—Hyperhidrosis—Irinotecan—lung cancer	0.00193	0.00216	CcSEcCtD
Levorphanol—Dizziness—Vinblastine—lung cancer	0.00192	0.00216	CcSEcCtD
Levorphanol—Convulsion—Cisplatin—lung cancer	0.00192	0.00216	CcSEcCtD
Levorphanol—Urticaria—Vinorelbine—lung cancer	0.00192	0.00216	CcSEcCtD
Levorphanol—Muscle spasms—Paclitaxel—lung cancer	0.00192	0.00215	CcSEcCtD
Levorphanol—Mood swings—Methotrexate—lung cancer	0.00192	0.00215	CcSEcCtD
Levorphanol—Abdominal pain—Vinorelbine—lung cancer	0.00191	0.00215	CcSEcCtD
Levorphanol—Hyperhidrosis—Gemcitabine—lung cancer	0.00188	0.00211	CcSEcCtD
Levorphanol—Visual impairment—Docetaxel—lung cancer	0.00187	0.0021	CcSEcCtD
Levorphanol—Dizziness—Topotecan—lung cancer	0.00187	0.0021	CcSEcCtD
Levorphanol—Hypotension—Irinotecan—lung cancer	0.00186	0.00209	CcSEcCtD
Levorphanol—Vomiting—Vinblastine—lung cancer	0.00185	0.00208	CcSEcCtD
Levorphanol—Dizziness—Erlotinib—lung cancer	0.00185	0.00208	CcSEcCtD
Levorphanol—Agitation—Paclitaxel—lung cancer	0.00183	0.00206	CcSEcCtD
Levorphanol—Hypotension—Gemcitabine—lung cancer	0.00182	0.00204	CcSEcCtD
Levorphanol—Dextromethorphan—CYP2E1—lung cancer	0.00181	0.0473	CrCbGaD
Levorphanol—Insomnia—Irinotecan—lung cancer	0.0018	0.00203	CcSEcCtD
Levorphanol—Flushing—Docetaxel—lung cancer	0.0018	0.00202	CcSEcCtD
Levorphanol—Vomiting—Topotecan—lung cancer	0.0018	0.00202	CcSEcCtD
Levorphanol—Lethargy—Doxorubicin—lung cancer	0.00179	0.00201	CcSEcCtD
Levorphanol—Rash—Topotecan—lung cancer	0.00178	0.002	CcSEcCtD
Levorphanol—Dermatitis—Topotecan—lung cancer	0.00178	0.002	CcSEcCtD
Levorphanol—Vomiting—Erlotinib—lung cancer	0.00178	0.002	CcSEcCtD
Levorphanol—Tachycardia—Cisplatin—lung cancer	0.00177	0.00198	CcSEcCtD
Levorphanol—Rash—Erlotinib—lung cancer	0.00176	0.00198	CcSEcCtD
Levorphanol—Dermatitis—Erlotinib—lung cancer	0.00176	0.00198	CcSEcCtD
Levorphanol—Palpitations—Paclitaxel—lung cancer	0.00176	0.00198	CcSEcCtD
Levorphanol—Convulsion—Etoposide—lung cancer	0.00176	0.00198	CcSEcCtD
Levorphanol—Insomnia—Gemcitabine—lung cancer	0.00176	0.00197	CcSEcCtD
Levorphanol—Dyspepsia—Irinotecan—lung cancer	0.00176	0.00197	CcSEcCtD
Levorphanol—Diplopia—Doxorubicin—lung cancer	0.00175	0.00197	CcSEcCtD
Levorphanol—Hyperhidrosis—Cisplatin—lung cancer	0.00175	0.00197	CcSEcCtD
Levorphanol—Arrhythmia—Docetaxel—lung cancer	0.00173	0.00195	CcSEcCtD
Levorphanol—Estrone—CYP2E1—lung cancer	0.00173	0.0454	CrCbGaD
Levorphanol—Nausea—Vinblastine—lung cancer	0.00173	0.00194	CcSEcCtD
Levorphanol—Convulsion—Paclitaxel—lung cancer	0.00173	0.00194	CcSEcCtD
Levorphanol—Affect lability—Doxorubicin—lung cancer	0.00172	0.00193	CcSEcCtD
Levorphanol—Pruritus—Vinorelbine—lung cancer	0.00171	0.00192	CcSEcCtD
Levorphanol—Estrone—CYP1A1—lung cancer	0.00171	0.0448	CrCbGaD
Levorphanol—Constipation—Irinotecan—lung cancer	0.00171	0.00191	CcSEcCtD
Levorphanol—Hypotension—Cisplatin—lung cancer	0.00169	0.0019	CcSEcCtD
Levorphanol—Nausea—Topotecan—lung cancer	0.00168	0.00189	CcSEcCtD
Levorphanol—Confusional state—Etoposide—lung cancer	0.00167	0.00188	CcSEcCtD
Levorphanol—Cardiac arrest—Doxorubicin—lung cancer	0.00166	0.00187	CcSEcCtD
Levorphanol—Constipation—Gemcitabine—lung cancer	0.00166	0.00187	CcSEcCtD
Levorphanol—Nausea—Erlotinib—lung cancer	0.00166	0.00187	CcSEcCtD
Levorphanol—Dry mouth—Paclitaxel—lung cancer	0.00166	0.00186	CcSEcCtD
Levorphanol—Mood swings—Doxorubicin—lung cancer	0.00166	0.00186	CcSEcCtD
Levorphanol—Estradiol—ABCG2—lung cancer	0.00165	0.0433	CrCbGaD
Levorphanol—Feeling abnormal—Irinotecan—lung cancer	0.00164	0.00185	CcSEcCtD
Levorphanol—Confusional state—Paclitaxel—lung cancer	0.00164	0.00184	CcSEcCtD
Levorphanol—Dysuria—Methotrexate—lung cancer	0.00163	0.00183	CcSEcCtD
Levorphanol—Gastrointestinal pain—Irinotecan—lung cancer	0.00163	0.00183	CcSEcCtD
Levorphanol—Muscle spasms—Docetaxel—lung cancer	0.00162	0.00182	CcSEcCtD
Levorphanol—Tachycardia—Etoposide—lung cancer	0.00162	0.00182	CcSEcCtD
Levorphanol—Hyperhidrosis—Etoposide—lung cancer	0.0016	0.0018	CcSEcCtD
Levorphanol—Feeling abnormal—Gemcitabine—lung cancer	0.0016	0.0018	CcSEcCtD
Levorphanol—Shock—Paclitaxel—lung cancer	0.0016	0.0018	CcSEcCtD
Levorphanol—Dizziness—Vinorelbine—lung cancer	0.0016	0.0018	CcSEcCtD
Levorphanol—Tachycardia—Paclitaxel—lung cancer	0.00159	0.00178	CcSEcCtD
Levorphanol—Abdominal pain—Irinotecan—lung cancer	0.00158	0.00177	CcSEcCtD
Levorphanol—Hyperhidrosis—Paclitaxel—lung cancer	0.00157	0.00177	CcSEcCtD
Levorphanol—Hypotension—Etoposide—lung cancer	0.00155	0.00174	CcSEcCtD
Levorphanol—Vomiting—Vinorelbine—lung cancer	0.00154	0.00173	CcSEcCtD
Levorphanol—Renal failure—Methotrexate—lung cancer	0.00153	0.00172	CcSEcCtD
Levorphanol—Rash—Vinorelbine—lung cancer	0.00152	0.00171	CcSEcCtD
Levorphanol—Dermatitis—Vinorelbine—lung cancer	0.00152	0.00171	CcSEcCtD
Levorphanol—Hypotension—Paclitaxel—lung cancer	0.00152	0.00171	CcSEcCtD
Levorphanol—Sweating—Methotrexate—lung cancer	0.00149	0.00168	CcSEcCtD
Levorphanol—Palpitations—Docetaxel—lung cancer	0.00149	0.00168	CcSEcCtD
Levorphanol—Feeling abnormal—Cisplatin—lung cancer	0.00149	0.00168	CcSEcCtD
Levorphanol—Insomnia—Paclitaxel—lung cancer	0.00147	0.00165	CcSEcCtD
Levorphanol—Convulsion—Docetaxel—lung cancer	0.00146	0.00164	CcSEcCtD
Levorphanol—Nausea—Vinorelbine—lung cancer	0.00144	0.00161	CcSEcCtD
Levorphanol—Dyspepsia—Paclitaxel—lung cancer	0.00143	0.00161	CcSEcCtD
Levorphanol—Constipation—Etoposide—lung cancer	0.00142	0.00159	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—lung cancer	0.00141	0.00159	CcSEcCtD
Levorphanol—Dry mouth—Docetaxel—lung cancer	0.00141	0.00158	CcSEcCtD
Levorphanol—Constipation—Paclitaxel—lung cancer	0.00139	0.00156	CcSEcCtD
Levorphanol—Confusional state—Docetaxel—lung cancer	0.00139	0.00156	CcSEcCtD
Levorphanol—Pruritus—Gemcitabine—lung cancer	0.00137	0.00154	CcSEcCtD
Levorphanol—Feeling abnormal—Etoposide—lung cancer	0.00137	0.00153	CcSEcCtD
Levorphanol—Gastrointestinal pain—Etoposide—lung cancer	0.00136	0.00152	CcSEcCtD
Levorphanol—Shock—Docetaxel—lung cancer	0.00136	0.00152	CcSEcCtD
Levorphanol—Visual impairment—Methotrexate—lung cancer	0.00135	0.00151	CcSEcCtD
Levorphanol—Tachycardia—Docetaxel—lung cancer	0.00135	0.00151	CcSEcCtD
Levorphanol—Feeling abnormal—Paclitaxel—lung cancer	0.00134	0.0015	CcSEcCtD
Levorphanol—Gastrointestinal pain—Paclitaxel—lung cancer	0.00133	0.00149	CcSEcCtD
Levorphanol—Renal failure—Doxorubicin—lung cancer	0.00133	0.00149	CcSEcCtD
Levorphanol—Dizziness—Irinotecan—lung cancer	0.00132	0.00148	CcSEcCtD
Levorphanol—Urticaria—Etoposide—lung cancer	0.00132	0.00148	CcSEcCtD
Levorphanol—Abdominal pain—Etoposide—lung cancer	0.00131	0.00147	CcSEcCtD
Levorphanol—Estradiol—CYP1A1—lung cancer	0.0013	0.0339	CrCbGaD
Levorphanol—Sweating—Doxorubicin—lung cancer	0.00129	0.00145	CcSEcCtD
Levorphanol—Urticaria—Paclitaxel—lung cancer	0.00129	0.00145	CcSEcCtD
Levorphanol—Hypotension—Docetaxel—lung cancer	0.00129	0.00145	CcSEcCtD
Levorphanol—Abdominal pain—Paclitaxel—lung cancer	0.00129	0.00144	CcSEcCtD
Levorphanol—Vomiting—Irinotecan—lung cancer	0.00127	0.00142	CcSEcCtD
Levorphanol—Rash—Irinotecan—lung cancer	0.00126	0.00141	CcSEcCtD
Levorphanol—Dermatitis—Irinotecan—lung cancer	0.00126	0.00141	CcSEcCtD
Levorphanol—Insomnia—Docetaxel—lung cancer	0.00125	0.0014	CcSEcCtD
Levorphanol—Vomiting—Gemcitabine—lung cancer	0.00124	0.00139	CcSEcCtD
Levorphanol—Bradycardia—Doxorubicin—lung cancer	0.00123	0.00138	CcSEcCtD
Levorphanol—Rash—Gemcitabine—lung cancer	0.00122	0.00138	CcSEcCtD
Levorphanol—Dermatitis—Gemcitabine—lung cancer	0.00122	0.00137	CcSEcCtD
Levorphanol—Dyspepsia—Docetaxel—lung cancer	0.00121	0.00136	CcSEcCtD
Levorphanol—Nausea—Irinotecan—lung cancer	0.00118	0.00133	CcSEcCtD
Levorphanol—Constipation—Docetaxel—lung cancer	0.00118	0.00132	CcSEcCtD
Levorphanol—Pruritus—Etoposide—lung cancer	0.00117	0.00132	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—lung cancer	0.00117	0.00131	CcSEcCtD
Levorphanol—Nausea—Gemcitabine—lung cancer	0.00115	0.0013	CcSEcCtD
Levorphanol—Vomiting—Cisplatin—lung cancer	0.00115	0.00129	CcSEcCtD
Levorphanol—Pruritus—Paclitaxel—lung cancer	0.00115	0.00129	CcSEcCtD
Levorphanol—Rash—Cisplatin—lung cancer	0.00114	0.00128	CcSEcCtD
Levorphanol—Dermatitis—Cisplatin—lung cancer	0.00114	0.00128	CcSEcCtD
Levorphanol—Feeling abnormal—Docetaxel—lung cancer	0.00114	0.00128	CcSEcCtD
Levorphanol—Gastrointestinal pain—Docetaxel—lung cancer	0.00113	0.00127	CcSEcCtD
Levorphanol—Morphine—ABCB1—lung cancer	0.00113	0.0295	CrCbGaD
Levorphanol—Flushing—Doxorubicin—lung cancer	0.00112	0.00126	CcSEcCtD
Levorphanol—Dizziness—Etoposide—lung cancer	0.0011	0.00123	CcSEcCtD
Levorphanol—Abdominal pain—Docetaxel—lung cancer	0.00109	0.00122	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—lung cancer	0.00108	0.00121	CcSEcCtD
Levorphanol—Dizziness—Paclitaxel—lung cancer	0.00108	0.00121	CcSEcCtD
Levorphanol—Nausea—Cisplatin—lung cancer	0.00108	0.00121	CcSEcCtD
Levorphanol—Convulsion—Methotrexate—lung cancer	0.00105	0.00118	CcSEcCtD
Levorphanol—Vomiting—Etoposide—lung cancer	0.00105	0.00118	CcSEcCtD
Levorphanol—Rash—Etoposide—lung cancer	0.00105	0.00117	CcSEcCtD
Levorphanol—Dermatitis—Etoposide—lung cancer	0.00105	0.00117	CcSEcCtD
Levorphanol—Tension—Doxorubicin—lung cancer	0.00103	0.00116	CcSEcCtD
Levorphanol—Vomiting—Paclitaxel—lung cancer	0.00103	0.00116	CcSEcCtD
Levorphanol—Rash—Paclitaxel—lung cancer	0.00103	0.00115	CcSEcCtD
Levorphanol—Dermatitis—Paclitaxel—lung cancer	0.00102	0.00115	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—lung cancer	0.00102	0.00115	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—lung cancer	0.00101	0.00114	CcSEcCtD
Levorphanol—Confusional state—Methotrexate—lung cancer	0.001	0.00112	CcSEcCtD
Levorphanol—Nausea—Etoposide—lung cancer	0.000985	0.00111	CcSEcCtD
Levorphanol—Pruritus—Docetaxel—lung cancer	0.000975	0.0011	CcSEcCtD
Levorphanol—Agitation—Doxorubicin—lung cancer	0.000969	0.00109	CcSEcCtD
Levorphanol—Nausea—Paclitaxel—lung cancer	0.000966	0.00108	CcSEcCtD
Levorphanol—Hyperhidrosis—Methotrexate—lung cancer	0.000961	0.00108	CcSEcCtD
Levorphanol—Estrone—ALB—lung cancer	0.000952	0.0249	CrCbGaD
Levorphanol—Dextromethorphan—ABCB1—lung cancer	0.000946	0.0248	CrCbGaD
Levorphanol—Palpitations—Doxorubicin—lung cancer	0.000932	0.00105	CcSEcCtD
Levorphanol—Hypotension—Methotrexate—lung cancer	0.000929	0.00104	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—lung cancer	0.000913	0.00103	CcSEcCtD
Levorphanol—Dizziness—Docetaxel—lung cancer	0.000912	0.00102	CcSEcCtD
Levorphanol—Estrone—ABCB1—lung cancer	0.000908	0.0238	CrCbGaD
Levorphanol—Insomnia—Methotrexate—lung cancer	0.000899	0.00101	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—lung cancer	0.000878	0.000986	CcSEcCtD
Levorphanol—Vomiting—Docetaxel—lung cancer	0.000877	0.000984	CcSEcCtD
Levorphanol—Dyspepsia—Methotrexate—lung cancer	0.000875	0.000982	CcSEcCtD
Levorphanol—Rash—Docetaxel—lung cancer	0.000869	0.000976	CcSEcCtD
Levorphanol—Dermatitis—Docetaxel—lung cancer	0.000868	0.000975	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—lung cancer	0.000868	0.000974	CcSEcCtD
Levorphanol—Shock—Doxorubicin—lung cancer	0.000847	0.00095	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—lung cancer	0.00084	0.000943	CcSEcCtD
Levorphanol—Hyperhidrosis—Doxorubicin—lung cancer	0.000832	0.000934	CcSEcCtD
Levorphanol—Nausea—Docetaxel—lung cancer	0.000819	0.000919	CcSEcCtD
Levorphanol—Feeling abnormal—Methotrexate—lung cancer	0.000819	0.000919	CcSEcCtD
Levorphanol—Gastrointestinal pain—Methotrexate—lung cancer	0.000813	0.000912	CcSEcCtD
Levorphanol—Hypotension—Doxorubicin—lung cancer	0.000804	0.000903	CcSEcCtD
Levorphanol—Urticaria—Methotrexate—lung cancer	0.000789	0.000886	CcSEcCtD
Levorphanol—Abdominal pain—Methotrexate—lung cancer	0.000786	0.000882	CcSEcCtD
Levorphanol—Insomnia—Doxorubicin—lung cancer	0.000778	0.000874	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—lung cancer	0.000757	0.00085	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—lung cancer	0.000736	0.000826	CcSEcCtD
Levorphanol—Estradiol—ALB—lung cancer	0.000721	0.0189	CrCbGaD
Levorphanol—Feeling abnormal—Doxorubicin—lung cancer	0.000709	0.000796	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—lung cancer	0.000704	0.00079	CcSEcCtD
Levorphanol—Pruritus—Methotrexate—lung cancer	0.000703	0.000789	CcSEcCtD
Levorphanol—Estradiol—ABCB1—lung cancer	0.000688	0.018	CrCbGaD
Levorphanol—Urticaria—Doxorubicin—lung cancer	0.000684	0.000767	CcSEcCtD
Levorphanol—Abdominal pain—Doxorubicin—lung cancer	0.00068	0.000764	CcSEcCtD
Levorphanol—Dizziness—Methotrexate—lung cancer	0.000657	0.000738	CcSEcCtD
Levorphanol—Vomiting—Methotrexate—lung cancer	0.000632	0.000709	CcSEcCtD
Levorphanol—Rash—Methotrexate—lung cancer	0.000627	0.000703	CcSEcCtD
Levorphanol—Dermatitis—Methotrexate—lung cancer	0.000626	0.000703	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—lung cancer	0.000609	0.000683	CcSEcCtD
Levorphanol—Nausea—Methotrexate—lung cancer	0.00059	0.000663	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—lung cancer	0.000569	0.000639	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—lung cancer	0.000547	0.000614	CcSEcCtD
Levorphanol—Rash—Doxorubicin—lung cancer	0.000543	0.000609	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—lung cancer	0.000542	0.000609	CcSEcCtD
Levorphanol—Nausea—Doxorubicin—lung cancer	0.000511	0.000574	CcSEcCtD
Levorphanol—OPRD1—Signaling Pathways—ANXA1—lung cancer	8.04e-05	0.00113	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SMARCA4—lung cancer	7.86e-05	0.00111	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PPP2R1B—lung cancer	7.86e-05	0.00111	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FLT1—lung cancer	7.78e-05	0.00109	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CG—lung cancer	7.71e-05	0.00108	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APP—lung cancer	7.62e-05	0.00107	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NOTCH3—lung cancer	7.62e-05	0.00107	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HSPB1—lung cancer	7.58e-05	0.00107	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—GNG11—lung cancer	7.58e-05	0.00107	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGF9—lung cancer	7.56e-05	0.00106	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTHLH—lung cancer	7.49e-05	0.00105	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CXCL8—lung cancer	7.44e-05	0.00105	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AVP—lung cancer	7.43e-05	0.00105	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—POMC—lung cancer	7.34e-05	0.00103	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VEGFC—lung cancer	7.21e-05	0.00101	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—JUNB—lung cancer	7.21e-05	0.00101	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ANXA1—lung cancer	7.05e-05	0.000991	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CG—lung cancer	7e-05	0.000985	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FLT1—lung cancer	6.82e-05	0.00096	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADCY1—lung cancer	6.81e-05	0.000958	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CD—lung cancer	6.78e-05	0.000953	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CG—lung cancer	6.76e-05	0.000951	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APP—lung cancer	6.68e-05	0.00094	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NOTCH3—lung cancer	6.68e-05	0.00094	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—POMC—lung cancer	6.66e-05	0.000937	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PPP2R1B—lung cancer	6.64e-05	0.000934	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SMARCA4—lung cancer	6.64e-05	0.000934	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGF9—lung cancer	6.62e-05	0.000932	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STK11—lung cancer	6.55e-05	0.000921	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6R—lung cancer	6.5e-05	0.000914	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—POMC—lung cancer	6.43e-05	0.000905	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HSPB1—lung cancer	6.41e-05	0.000901	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTHLH—lung cancer	6.33e-05	0.000891	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—JUNB—lung cancer	6.33e-05	0.00089	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FOXO3—lung cancer	6.32e-05	0.000889	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—MAP2K1—lung cancer	6.2e-05	0.000872	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CD—lung cancer	6.15e-05	0.000866	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CG—lung cancer	6.14e-05	0.000864	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ANXA1—lung cancer	5.96e-05	0.000838	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CD—lung cancer	5.94e-05	0.000836	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AVP—lung cancer	5.92e-05	0.000833	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CB—lung cancer	5.91e-05	0.000831	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—POMC—lung cancer	5.84e-05	0.000822	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FLT1—lung cancer	5.77e-05	0.000811	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STK11—lung cancer	5.74e-05	0.000808	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CG—lung cancer	5.71e-05	0.000804	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IGF1R—lung cancer	5.7e-05	0.000802	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6R—lung cancer	5.7e-05	0.000802	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCL8—lung cancer	5.68e-05	0.000799	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APP—lung cancer	5.65e-05	0.000794	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NOTCH3—lung cancer	5.65e-05	0.000794	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HES1—lung cancer	5.6e-05	0.000788	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGF9—lung cancer	5.6e-05	0.000788	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FOXO3—lung cancer	5.54e-05	0.00078	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—RAF1—lung cancer	5.49e-05	0.000773	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—POMC—lung cancer	5.44e-05	0.000765	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MAP2K1—lung cancer	5.43e-05	0.000764	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—IL2—lung cancer	5.43e-05	0.000763	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CD—lung cancer	5.4e-05	0.000759	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CB—lung cancer	5.36e-05	0.000755	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—JUNB—lung cancer	5.35e-05	0.000752	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AVP—lung cancer	5.19e-05	0.000731	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CG—lung cancer	5.19e-05	0.00073	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CB—lung cancer	5.18e-05	0.000729	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCL8—lung cancer	5.16e-05	0.000725	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ERBB3—lung cancer	5.12e-05	0.00072	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CD—lung cancer	5.02e-05	0.000707	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IGF1R—lung cancer	5e-05	0.000703	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCL8—lung cancer	4.98e-05	0.0007	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—POMC—lung cancer	4.94e-05	0.000695	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL2—lung cancer	4.93e-05	0.000693	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HES1—lung cancer	4.91e-05	0.000691	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TERT—lung cancer	4.91e-05	0.000691	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STK11—lung cancer	4.85e-05	0.000683	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—RAF1—lung cancer	4.82e-05	0.000678	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6R—lung cancer	4.82e-05	0.000678	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—FGFR1—lung cancer	4.77e-05	0.00067	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—IL2—lung cancer	4.76e-05	0.000669	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CB—lung cancer	4.7e-05	0.000662	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HIF1A—lung cancer	4.69e-05	0.00066	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FOXO3—lung cancer	4.69e-05	0.000659	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MAP2K1—lung cancer	4.59e-05	0.000646	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CD—lung cancer	4.56e-05	0.000642	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APOA1—lung cancer	4.53e-05	0.000637	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCL8—lung cancer	4.52e-05	0.000636	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ERBB3—lung cancer	4.49e-05	0.000632	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KDR—lung cancer	4.49e-05	0.000632	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AVP—lung cancer	4.39e-05	0.000618	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CB—lung cancer	4.38e-05	0.000616	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL2—lung cancer	4.32e-05	0.000608	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TERT—lung cancer	4.3e-05	0.000605	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IGF1R—lung cancer	4.23e-05	0.000594	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCL8—lung cancer	4.21e-05	0.000592	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—FGFR1—lung cancer	4.18e-05	0.000588	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HES1—lung cancer	4.15e-05	0.000584	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—APC—lung cancer	4.14e-05	0.000582	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KIT—lung cancer	4.14e-05	0.000582	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CG—lung cancer	4.14e-05	0.000582	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—NRAS—lung cancer	4.14e-05	0.000582	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HIF1A—lung cancer	4.12e-05	0.000579	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGF—lung cancer	4.09e-05	0.000575	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—RAF1—lung cancer	4.07e-05	0.000573	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—IL2—lung cancer	4.02e-05	0.000566	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CB—lung cancer	3.98e-05	0.000559	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APOA1—lung cancer	3.97e-05	0.000559	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—MAPK3—lung cancer	3.96e-05	0.000557	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—POMC—lung cancer	3.94e-05	0.000554	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KDR—lung cancer	3.94e-05	0.000554	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—BRAF—lung cancer	3.89e-05	0.000547	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6R—lung cancer	3.84e-05	0.00054	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CREBBP—lung cancer	3.83e-05	0.000539	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL8—lung cancer	3.82e-05	0.000537	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ERBB3—lung cancer	3.8e-05	0.000534	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—EGFR—lung cancer	3.77e-05	0.00053	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAP2K1—lung cancer	3.66e-05	0.000515	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL2—lung cancer	3.65e-05	0.000514	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TERT—lung cancer	3.64e-05	0.000512	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CD—lung cancer	3.64e-05	0.000511	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KIT—lung cancer	3.63e-05	0.00051	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—APC—lung cancer	3.63e-05	0.00051	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CG—lung cancer	3.63e-05	0.00051	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—NRAS—lung cancer	3.63e-05	0.00051	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—PIK3CA—lung cancer	3.6e-05	0.000507	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGF—lung cancer	3.58e-05	0.000504	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—KRAS—lung cancer	3.56e-05	0.000501	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—FGFR1—lung cancer	3.53e-05	0.000497	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HIF1A—lung cancer	3.48e-05	0.000489	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—MAPK3—lung cancer	3.47e-05	0.000489	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—POMC—lung cancer	3.45e-05	0.000486	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—BRAF—lung cancer	3.41e-05	0.00048	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6R—lung cancer	3.37e-05	0.000474	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CREBBP—lung cancer	3.36e-05	0.000473	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APOA1—lung cancer	3.36e-05	0.000472	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KDR—lung cancer	3.33e-05	0.000468	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—EGFR—lung cancer	3.3e-05	0.000465	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—PIK3CA—lung cancer	3.27e-05	0.00046	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MDM2—lung cancer	3.26e-05	0.000458	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RAF1—lung cancer	3.25e-05	0.000457	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ERBB2—lung cancer	3.21e-05	0.000452	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAP2K1—lung cancer	3.21e-05	0.000451	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CD—lung cancer	3.19e-05	0.000448	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MTOR—lung cancer	3.17e-05	0.000446	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CB—lung cancer	3.17e-05	0.000446	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—PIK3CA—lung cancer	3.16e-05	0.000444	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—KRAS—lung cancer	3.12e-05	0.000439	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CG—lung cancer	3.06e-05	0.000431	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—APC—lung cancer	3.06e-05	0.000431	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KIT—lung cancer	3.06e-05	0.000431	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—NRAS—lung cancer	3.06e-05	0.000431	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL8—lung cancer	3.05e-05	0.000428	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGF—lung cancer	3.03e-05	0.000426	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—HRAS—lung cancer	3.03e-05	0.000426	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AKT1—lung cancer	2.94e-05	0.000414	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—MAPK3—lung cancer	2.94e-05	0.000413	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—POMC—lung cancer	2.92e-05	0.00041	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CASP3—lung cancer	2.91e-05	0.00041	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL2—lung cancer	2.91e-05	0.000409	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—IL6—lung cancer	2.9e-05	0.000407	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—BRAF—lung cancer	2.88e-05	0.000405	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—PIK3CA—lung cancer	2.87e-05	0.000403	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MDM2—lung cancer	2.86e-05	0.000402	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RAF1—lung cancer	2.85e-05	0.0004	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6R—lung cancer	2.85e-05	0.0004	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CREBBP—lung cancer	2.84e-05	0.0004	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CCND1—lung cancer	2.84e-05	0.000399	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—JUN—lung cancer	2.83e-05	0.000398	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ERBB2—lung cancer	2.82e-05	0.000396	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—EGFR—lung cancer	2.79e-05	0.000393	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MTOR—lung cancer	2.78e-05	0.000391	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CB—lung cancer	2.78e-05	0.000391	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MMP9—lung cancer	2.75e-05	0.000387	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CDKN1A—lung cancer	2.74e-05	0.000386	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PTEN—lung cancer	2.74e-05	0.000385	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAP2K1—lung cancer	2.71e-05	0.000382	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CD—lung cancer	2.69e-05	0.000379	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AKT1—lung cancer	2.67e-05	0.000376	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL8—lung cancer	2.67e-05	0.000376	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	2.67e-05	0.000375	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—HRAS—lung cancer	2.65e-05	0.000373	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—KRAS—lung cancer	2.64e-05	0.000371	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EP300—lung cancer	2.61e-05	0.000367	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AKT1—lung cancer	2.58e-05	0.000363	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CASP3—lung cancer	2.56e-05	0.00036	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL2—lung cancer	2.55e-05	0.000359	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—SRC—lung cancer	2.54e-05	0.000357	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—IL6—lung cancer	2.54e-05	0.000357	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CCND1—lung cancer	2.49e-05	0.00035	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—JUN—lung cancer	2.48e-05	0.000349	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—VEGFA—lung cancer	2.47e-05	0.000348	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—STAT3—lung cancer	2.45e-05	0.000345	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—NRAS—lung cancer	2.44e-05	0.000344	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	2.42e-05	0.000341	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MMP9—lung cancer	2.42e-05	0.00034	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MDM2—lung cancer	2.41e-05	0.00034	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CDKN1A—lung cancer	2.41e-05	0.000339	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RAF1—lung cancer	2.41e-05	0.000338	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PTEN—lung cancer	2.4e-05	0.000338	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ERBB2—lung cancer	2.38e-05	0.000335	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MTOR—lung cancer	2.35e-05	0.00033	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CB—lung cancer	2.35e-05	0.00033	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AKT1—lung cancer	2.34e-05	0.00033	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MAPK3—lung cancer	2.34e-05	0.000329	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EP300—lung cancer	2.29e-05	0.000322	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—MYC—lung cancer	2.28e-05	0.00032	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL8—lung cancer	2.26e-05	0.000317	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—HRAS—lung cancer	2.24e-05	0.000315	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—SRC—lung cancer	2.23e-05	0.000313	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGFR—lung cancer	2.23e-05	0.000313	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AKT1—lung cancer	2.18e-05	0.000307	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—VEGFA—lung cancer	2.17e-05	0.000305	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CASP3—lung cancer	2.16e-05	0.000304	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL2—lung cancer	2.16e-05	0.000303	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—STAT3—lung cancer	2.15e-05	0.000302	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—IL6—lung cancer	2.15e-05	0.000302	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—NRAS—lung cancer	2.14e-05	0.000301	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—KRAS—lung cancer	2.1e-05	0.000296	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CCND1—lung cancer	2.1e-05	0.000296	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—JUN—lung cancer	2.1e-05	0.000295	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MAPK3—lung cancer	2.05e-05	0.000289	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MMP9—lung cancer	2.04e-05	0.000287	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CDKN1A—lung cancer	2.03e-05	0.000286	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PTEN—lung cancer	2.03e-05	0.000285	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—MYC—lung cancer	2e-05	0.000281	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AKT1—lung cancer	1.98e-05	0.000279	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGFR—lung cancer	1.95e-05	0.000275	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EP300—lung cancer	1.94e-05	0.000272	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PIK3CA—lung cancer	1.93e-05	0.000272	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—SRC—lung cancer	1.88e-05	0.000265	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—TP53—lung cancer	1.87e-05	0.000263	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—KRAS—lung cancer	1.84e-05	0.000259	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—VEGFA—lung cancer	1.83e-05	0.000258	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—STAT3—lung cancer	1.81e-05	0.000255	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—NRAS—lung cancer	1.81e-05	0.000255	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—HRAS—lung cancer	1.79e-05	0.000251	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MAPK3—lung cancer	1.73e-05	0.000244	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—IL6—lung cancer	1.71e-05	0.000241	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PIK3CA—lung cancer	1.69e-05	0.000238	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—MYC—lung cancer	1.69e-05	0.000237	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGFR—lung cancer	1.65e-05	0.000232	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—TP53—lung cancer	1.64e-05	0.000231	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AKT1—lung cancer	1.58e-05	0.000222	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—HRAS—lung cancer	1.57e-05	0.00022	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—KRAS—lung cancer	1.56e-05	0.000219	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—IL6—lung cancer	1.5e-05	0.000211	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PIK3CA—lung cancer	1.43e-05	0.000201	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—TP53—lung cancer	1.39e-05	0.000195	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AKT1—lung cancer	1.38e-05	0.000195	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—HRAS—lung cancer	1.32e-05	0.000186	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—IL6—lung cancer	1.27e-05	0.000178	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AKT1—lung cancer	1.17e-05	0.000165	CbGpPWpGaD
